According to regulatory filings, annual revenue rose from KRW 1.01 billion in 2023 to KRW 9.3 billion in 2024 (up 819.6% year on year) and reached KRW 10.7 billion in 2025 (up 15.0% year on year). Revenue increased for two consecutive years from 2024 to 2025, and 2025 was the largest year of the 2023–2025 period.
Over the same period, the operating loss was KRW 9.52 billion in 2023, KRW 4.45 billion in 2024 and KRW 6.38 billion in 2025, meaning the company posted operating losses for three straight years from 2023 to 2025.
The loss narrowed in 2024 and widened again in 2025, and the operating margin was -940.9% in 2023, -47.8% in 2024 and -59.7% in 2025. The company cited two factors behind the weaker 2025 results: listing fees, a one-off cost of the listing process, and higher personnel expenses from newly hired R&D staff.
Net loss attributable to controlling shareholders was KRW 9.76 billion in 2023, KRW 4.97 billion in 2024 and KRW 6.87 billion in 2025, and the net loss including non-controlling interests was KRW 6.93 billion in 2025.
The debt-to-equity ratio fell from 181.4% in 2023 and 176.7% in 2024 to 66.2% in 2025, largely because total equity increased to KRW 30.8 billion at the end of 2025. Operating cash flow swung from positive KRW 1.76 billion in 2023 and KRW 1.07 billion in 2024 to negative KRW 4.55 billion in 2025.
On a quarterly basis, the filed results contain no data for the third and fourth quarters of 2025, and the figures for 2026 vary widely: revenue was KRW 270 million in Q1, KRW 1.53 billion in Q2 (up 457.0% quarter on quarter) and KRW 25 million in Q3 (down 98.4% quarter on quarter).
The operating loss narrowed from KRW 4.42 billion in Q1 2026 to KRW 2.37 billion in Q2, then widened again to KRW 3.68 billion in Q3, and the net loss attributable to controlling shareholders was KRW 3.86 billion in Q3.
The combined net loss attributable to controlling shareholders over the most recent four quarters (Q1 2025 to Q4 2025) is KRW 6.87 billion.
Because quarterly revenue moves with the timing of recognition of technology fees and milestone payments, the pattern in which revenue concentrated in Q2 almost disappeared in Q3 can be read as a sign that the company's base of recurring revenue is still weak.